TRP_1170x120_3-8-19

finasteride tablets

Mylan launches pair of new generics in U.S.

Mylan launches pair of new generics in U.S.

PITTSBURGH — Mylan N.V. this week introduced two new generic drugs in the U.S. market. On Monday, the company announced final Food and Drug Administration approval for dextroamphetamine sulfate extended-release capsules — in dosages of 5 mg, 10 mg and 15 mg — and finasteride tablets 1 mg. Mylan’s dextroamphetamine sulfate ER capsules are a